Annual Shareholders Equity
$3.76 M
+$3.03 M+413.95%
01 June 2024
Summary:
Kintara Therapeutics annual stockholders equity is currently $3.76 million, with the most recent change of +$3.03 million (+413.95%) on 01 June 2024. During the last 3 years, it has fallen by -$6.82 million (-64.49%).KTRA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$3.76 M
-$2.17 M-36.56%
01 June 2024
Summary:
Kintara Therapeutics quarterly stockholders equity is currently $3.76 million, with the most recent change of -$2.17 million (-36.56%) on 01 June 2024. Over the past year, it has increased by +$5.78 million (+285.44%).KTRA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KTRA Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +413.9% | +285.4% |
| 3 y3 years | -64.5% | -80.4% |
| 5 y5 years | +91.0% | -46.5% |
KTRA Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -68.1% | -81.7% |
Kintara Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | $3.76 M(+414.0%) | $3.76 M(-36.6%) |
| Mar 2024 | - | $5.92 M(-3711.0%) |
| Dec 2023 | - | -$164.00 K(-91.9%) |
| Sept 2023 | - | -$2.03 M(-377.2%) |
| June 2023 | $731.00 K(-93.8%) | $731.00 K(-80.7%) |
| Mar 2023 | - | $3.79 M(-42.6%) |
| Dec 2022 | - | $6.60 M(-31.4%) |
| Sept 2022 | - | $9.62 M(-18.5%) |
| June 2022 | $11.79 M(+11.5%) | $11.79 M(+25.7%) |
| Mar 2022 | - | $9.39 M(-33.4%) |
| Dec 2021 | - | $14.10 M(-26.4%) |
| Sept 2021 | - | $19.16 M(+81.1%) |
| June 2021 | $10.58 M(+3923.2%) | $10.58 M(-34.4%) |
| Mar 2021 | - | $16.12 M(-8.3%) |
| Dec 2020 | - | $17.59 M(-14.4%) |
| Sept 2020 | - | $20.55 M(+7715.2%) |
| June 2020 | $263.00 K(-86.6%) | $263.00 K(-92.9%) |
| Mar 2020 | - | $3.72 M(-32.1%) |
| Dec 2019 | - | $5.48 M(-22.0%) |
| Sept 2019 | - | $7.02 M(+257.0%) |
| June 2019 | $1.97 M(-63.8%) | $1.97 M(+56.3%) |
| Mar 2019 | - | $1.26 M(-54.5%) |
| Dec 2018 | - | $2.77 M(-24.6%) |
| Sept 2018 | - | $3.67 M(-32.5%) |
| June 2018 | $5.44 M(-17.4%) | $5.44 M(-29.0%) |
| Mar 2018 | - | $7.66 M(-23.3%) |
| Dec 2017 | - | $9.98 M(-22.7%) |
| Sept 2017 | - | $12.92 M(+96.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2017 | $6.58 M(+35.4%) | $6.58 M(+434.8%) |
| Mar 2017 | - | $1.23 M(-54.5%) |
| Dec 2016 | - | $2.70 M(-32.0%) |
| Sept 2016 | - | $3.97 M(-18.2%) |
| June 2016 | $4.86 M(-691.5%) | $4.86 M(-806.6%) |
| Mar 2016 | - | -$687.60 K(-689.2%) |
| Dec 2015 | - | $116.70 K(-122.7%) |
| Sept 2015 | - | -$514.50 K(-37.4%) |
| June 2015 | -$821.50 K(-193.3%) | -$821.50 K(-167.5%) |
| Mar 2015 | - | $1.22 M(-41.7%) |
| Dec 2014 | - | $2.09 M(+300.6%) |
| Sept 2014 | - | $520.90 K(-117.0%) |
| June 2014 | $880.50 K(-207.6%) | - |
| Mar 2014 | - | -$3.06 M(+274.1%) |
| Dec 2013 | -$818.00 K(+9875.6%) | -$818.00 K(+168.8%) |
| Sept 2013 | - | -$304.30 K(-96.1%) |
| June 2013 | - | -$7.71 M(+282.0%) |
| Mar 2013 | - | -$2.02 M(>+9900.0%) |
| Dec 2012 | - | -$15.60 K(+26.8%) |
| Sept 2012 | - | -$12.30 K(+50.0%) |
| June 2012 | - | -$8200.00(+13.9%) |
| June 2012 | -$8200.00(-176.6%) | - |
| Mar 2012 | - | -$7200.00(+75.6%) |
| Dec 2011 | - | -$4100.00(-160.3%) |
| Sept 2011 | - | $6800.00(-36.4%) |
| June 2011 | $10.70 K(-75.6%) | $10.70 K(-38.9%) |
| Mar 2011 | - | $17.50 K(-18.2%) |
| Dec 2010 | - | $21.40 K(-51.3%) |
| June 2010 | $43.90 K | $43.90 K |
FAQ
- What is Kintara Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Kintara Therapeutics?
- What is Kintara Therapeutics annual shareholders equity year-on-year change?
- What is Kintara Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Kintara Therapeutics?
- What is Kintara Therapeutics quarterly shareholders equity year-on-year change?
What is Kintara Therapeutics annual stockholders equity?
The current annual shareholders equity of KTRA is $3.76 M
What is the all time high annual shareholders equity for Kintara Therapeutics?
Kintara Therapeutics all-time high annual stockholders equity is $11.79 M
What is Kintara Therapeutics annual shareholders equity year-on-year change?
Over the past year, KTRA annual stockholders equity has changed by +$3.03 M (+413.95%)
What is Kintara Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of KTRA is $3.76 M
What is the all time high quarterly shareholders equity for Kintara Therapeutics?
Kintara Therapeutics all-time high quarterly stockholders equity is $20.55 M
What is Kintara Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, KTRA quarterly stockholders equity has changed by +$5.78 M (+285.44%)